title: [Normalization of blood pressure and lipids in patients with diabetes].
abstract: Especially the macrovascular risk and the reduced life expectancy emphasize that besides the optimal glycemic control in diabetes, the associated factors of metabolic syndrome, namely hypertension and hyperlipidemia, have to be treated with equal intensity. This will minimize additional diseases (e. g., atherosclerosis, nephropathy, retinopathy) and take some of the strain from our health care system in the long run. This article contains the current guidelines for the optimal treatment of hypertension and hyperlipidemia in diabetic patients.
authors.affiliation: a_clemens@gmx.de
authors.forename: Andreas
authors.initials: A
authors.lastname: Clemens
authors.forename: Baptist
authors.initials: B
authors.lastname: Gallwitz
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents